NCT02118428 Clinical and Biological Efficacy of Mirasol-treated Fresh Whole Blood for the Prevention of Transfusion-transmitted Malaria Status COMPLETED Phase NA
NCT02115516 Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis Status COMPLETED Phase PHASE1
NCT02098590 Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous Infection Status COMPLETED Phase NA
NCT02094508 Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in Uganda Status COMPLETED Phase N/A
NCT02083887 A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian Infants Status COMPLETED Phase PHASE1
NCT02083406 Bioavailability Study of Oral OZ439 Prototype Formulations Administered With Piperaquine Phosphate (PQP) Status COMPLETED Phase PHASE1
NCT02083068 Evaluation of the Protective Efficacy of a Vaccine Derived From the Synthetic CS Protein of Plasmodium Vivax Status COMPLETED Phase PHASE2
NCT02080026 Target Antigens Induced by Plasmodium Falciparum Sporozoite Immunization Under Chemoprophylaxis Status COMPLETED Phase NA
NCT02043652 Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil Status COMPLETED Phase NA
NCT02015091 Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive Adults Status COMPLETED Phase PHASE1
NCT02013687 Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy Adults Status COMPLETED Phase PHASE1
NCT01994525 Immunization Via Mosquito Bite With Radiation-attenuated Sporozoites Status COMPLETED Phase PHASE1
NCT01988636 Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults Status COMPLETED Phase PHASE1
NCT01976780 In Vivo and In Vitro Efficacy of Artemisinin Combination Therapy Status COMPLETED Phase PHASE4